ResMed Inc. Financial Ratios — RSMDF Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	22.72	20.55	20.86	20.56	18.78	17.04	15.29	13.29	16.62	23.59	16.05	23.29	22.82	22.08	25.3
Return on Assets (%)	12.29	12.12	14.13	15.1	15.54	12.96	10.18	9.66	11.28	14.3	10.19	15.87	15.15	14.99	18.62
Return on Capital (%)	20.57	18.27	17.86	17.69	16.41	12.88	10.86	10.89	13.48	16.73	12.17	18.98	18.06	18.08	21.89
Return on Invested Capital (%)	12.22	12.13	14.74	16.38	16.63	14.51	12.48	12.16	16.76	18.86	12.5	19.58	18.57	19.21	21.99
Gross Margin (%)	59.63	59.97	62.11	63.65	60.24	58	56.72	57.04	57.32	58.09	57.53	56.57	55.78	56.67	59.36
EBITDA Margin (%)	27.15	27.79	28.6	31.18	28.73	28.43	27.53	29.07	30.18	33.49	34.53	33.43	31.96	34.16	37.37
Operating Margin (%)	21.47	21.51	23.43	26.46	24.38	23.7	22.1	23.94	24.4	27.36	28.54	28.01	27.28	29.54	32.79
Incremental Operating Margin (%)	15.61	21.92	41.4	139.67	-1.76	16.66	9.15	37.86	28.43	49.39	43.07	23.55	23.24	50.21	65.78
Pretax Margin (%)	24.43	24.26	25.43	27.72	25.96	23.91	20.26	22.28	19.91	24.79	27.64	26.84	26.09	27	32.6
Profit Margin (%)	18.26	18.62	20.28	22.2	21.02	19.17	16.56	13.49	15.52	21.02	14.84	21.78	21.25	21.79	27.22
Net Income to Common Margin (%)	18.26	18.62	20.28	22.2	21.02	19.17	16.56	13.49	15.52	21.02	14.84	21.78	21.25	21.79	27.22
Effective Tax Rate (%)	25.26	23.23	20.25	19.9	19.05	19.83	18.26	39.46	22.02	15.2	46.3	18.85	18.53	19.28	16.5
Dvd Payout Ratio (%)	- -	- -	31.65	40.99	44.56	47.71	54.44	63.21	52.33	36.21	47.78	31.48	28.78	27.65	22.19
Sustainable Growth Rate (%)	22.72	20.55	14.26	12.13	10.41	8.91	6.97	4.89	7.92	15.05	8.38	15.96	16.25	15.98	19.68

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	100	251	301	301	301	1,173	1,079	281	1,271	1,299	794	918	1,580	874	852
ST Debt	- -	- -	300	- -	- -	299	- -	11	12	33	36	32	32	35	40
LT Debt	100	251	1	301	301	873	1,079	270	1,259	1,266	758	886	1,548	839	811
Total Debt/EBITDA	0.3	0.66	0.69	0.62	0.62	2.24	1.9	0.41	1.62	1.31	0.72	0.77	1.17	0.55	0.44
Net Debt/EBITDA	-1.88	-1.47	-1.33	-1.25	-0.86	0.84	0.45	0.14	1.43	0.72	0.33	0.42	0.9	0.29	-0.28
Total Debt/EBIT	0.38	0.85	0.85	0.73	0.73	2.69	2.36	0.5	2	1.61	0.87	0.92	1.37	0.63	0.5
Net Debt/EBIT	-2.38	-1.9	-1.62	-1.47	-1.02	1.01	0.56	0.17	1.77	0.88	0.39	0.5	1.05	0.34	-0.32
EBITDA to Interest Expense	192	79.45	67.81	79.11	83.47	46.65	20.15	23.99	21.76	24.53	46.02	53.6	28.48	35.01	- -
EBITDA-CapEx/Interest Expense	150.46	66.69	56.57	65.87	71.02	40.59	17.62	21.47	19.62	21.91	41.15	46.61	25.66	32.5	- -
EBIT to Interest Expense	151.83	61.51	55.55	67.13	70.83	38.9	16.18	19.76	17.59	20.04	38.03	44.92	24.31	30.28	- -
Interest Expense	2	5	6	6	6	11	28	28	36	40	24	22	47	46	- -
Common Equity/Total Assets	53.77	63.96	71.34	75.43	90.6	66.35	66.8	79.4	59.33	61.77	65.15	70.93	63	72.64	74.41
Long-Term Debt/Equity (%)	5.78	15.6	0.05	17.11	18.94	51.53	55.02	13.11	60.75	50.7	26.27	26.36	37.48	17.24	13.6
Long-Term Debt/Capital (%)	8.25	15.5	0.04	14.45	13.2	26.2	31.77	9.95	33.95	30.63	19.57	19.55	26.54	14.3	11.7
Long-Term Debt/Total Assets (%)	4.83	11.73	0.03	12.74	13.78	26.82	31.1	8.81	30.65	27.6	16.03	17.38	22.93	12.2	9.93
Total Debt/Equity (%)	5.79	15.6	18.68	17.11	18.94	69.2	55.02	13.67	61.33	52.03	27.51	27.3	38.26	17.97	14.27
Total Debt/Capital (%)	8.26	15.5	16.02	14.45	13.2	35.18	31.77	10.37	34.27	31.44	20.49	20.25	27.08	14.9	12.28
Total Debt/Total Assets (%)	4.84	11.73	13.61	12.74	13.78	36.01	31.1	9.19	30.94	28.32	16.79	18.01	23.4	12.72	10.42
Net Debt to Equity	-36.7	-34.75	-35.72	-34.41	-26.25	26.04	13.09	4.5	54.23	28.55	12.48	14.92	29.38	9.64	-9.07
Net Debt/Capital (%)	-133.04	-69.1	-57.41	-51.44	-26.71	16.96	9.97	3.67	31.56	19.43	10.06	11.78	21.64	8.33	-9.45
EBITDA	338	380	433	485	482	523	569	680	787	990	1,104	1,196	1,350	1,600	1,923
EBITDA-CapEx	264	319	361	404	410	455	497	609	709	884	987	1,040	1,216	1,485	1,823
Operating Income (Loss)	267	294	355	411	409	436	457	560	636	809	912	1,002	1,152	1,384	1,687

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	3.52	3.2	1.53	3.36	2.69	1.15	2.28	0.37	0.26	0.77	0.32	0.4	0.3	0.26	1.19
Current Ratio	6.19	5.38	2.52	5.77	5.28	2.23	4.57	2.08	2.06	2.53	1.73	2.8	3.12	2.59	3.44
Quick Ratio	4.88	4.33	2.1	4.69	4.05	1.75	3.53	1.32	1.22	1.56	1	1.23	1.23	1.22	2.16
CFO/Avg Current Liab	1.09	1.66	0.97	0.93	1.43	1.21	0.83	1.16	0.86	1.38	0.97	0.44	0.96	1.68	1.82
Common Equity/Total Assets	53.77	63.96	71.34	75.43	90.6	66.35	66.8	79.4	59.33	61.77	65.15	70.93	63	72.64	74.41
Long-Term Debt/Equity (%)	5.78	15.6	0.05	17.11	18.94	51.53	55.02	13.11	60.75	50.7	26.27	26.36	37.48	17.24	13.6
Long-Term Debt/Capital (%)	8.25	15.5	0.04	14.45	13.2	26.2	31.77	9.95	33.95	30.63	19.57	19.55	26.54	14.3	11.7
Long-Term Debt/Total Assets (%)	4.83	11.73	0.03	12.74	13.78	26.82	31.1	8.81	30.65	27.6	16.03	17.38	22.93	12.2	9.93
Total Debt/Equity (%)	5.79	15.6	18.68	17.11	18.94	69.2	55.02	13.67	61.33	52.03	27.51	27.3	38.26	17.97	14.27
Total Debt/Capital (%)	8.26	15.5	16.02	14.45	13.2	35.18	31.77	10.37	34.27	31.44	20.49	20.25	27.08	14.9	12.28
Total Debt/Total Assets (%)	4.84	11.73	13.61	12.74	13.78	36.01	31.1	9.19	30.94	28.32	16.79	18.01	23.4	12.72	10.42
CFO/Total Liabilities	83.74	72.26	67.11	64.92	64.46	35.08	27.45	50.25	22.55	38.38	39.99	20.24	26.44	69.77	79.38
CFO/CapEx	3.88	6.27	5.61	4.82	5.33	8.08	5.79	7.07	5.94	7.57	6.31	2.25	5.17	12.2	17.4
Altman's Z-Score	2.79	7.65	10.04	10.05	13.3	7.03	8.27	14.1	9.78	12.05	15.51	15.89	11.97	12.85	13.54

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	4.96	4.91	5.04	4.59	4.65	4.94	4.96	5.01	5.15	5.9	5.87	6.01	6.59	6.08	5.79
Days Sales Outstanding	73.59	74.35	72.48	79.57	78.5	73.91	73.52	72.85	70.87	61.91	62.17	60.71	55.35	60.07	63.01
Inventory Turnover	2.6	2.92	3.58	3.63	3.24	3.28	3.63	3.74	3.6	3.23	3.11	2.59	2.14	2.23	2.39
Days Inventory Outstanding	140.53	124.98	101.84	100.51	112.72	111.39	100.54	97.49	101.44	112.89	117.47	141.05	170.24	163.64	152.71
Accounts Payable Turnover	9.17	9.46	9.43	8.01	9	8.63	10.13	10.84	11.45	10.39	10.21	12.38	13.69	9.55	8.52
Accounts Payable Turnover Days	39.8	38.58	38.72	45.59	40.58	42.27	36.05	33.66	31.88	35.13	35.75	29.47	26.67	38.24	42.86
Cash Conversion Cycle	174.32	160.75	135.61	134.48	150.64	143.02	138.02	136.68	140.43	139.67	143.89	172.29	198.93	185.48	172.86
Inventory to Cash Days	-66.94	-50.63	-29.36	-20.94	-34.22	-37.48	-27.02	-24.64	-30.57	-50.98	-55.31	-80.35	-114.89	-103.57	-89.7
Inventories	201	174	146	165	247	224	268	269	350	417	457	744	998	822	928
Raw Materials	74	66	47	54	74	67	76	75	81	128	155	355	459	356	367
Work In Process	4	2	2	3	3	4	4	2	2	3	5	3	4	3	3
Finished Goods	123	107	97	108	170	153	188	191	267	286	297	386	535	464	558
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	4,056	6,890	6,649	9,383	8,372	10,984	15,847	15,885	25,403	33,204	32,135	32,024	26,023	32,278
- Cash & Cash Equivalents	735	810	876	906	717	731	822	189	147	463	295	274	228	238	1,209
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	100	251	301	301	301	1,173	1,079	281	1,271	1,299	794	918	1,580	874	852
Enterprise Value	-635	3,497	6,315	6,044	8,967	8,814	11,240	15,940	17,009	26,240	33,702	32,778	33,376	26,658	31,920
Total Capital	1,213	1,618	1,878	2,082	2,277	3,334	3,395	2,714	3,708	4,133	3,874	4,532	5,834	5,866	6,934
Total Debt/Capital (%)	8.26	15.5	16.02	14.45	13.2	35.18	31.77	10.37	34.27	31.44	20.49	20.25	27.08	14.9	12.28
Total Debt / EV	-0.16	0.07	0.05	0.05	0.03	0.13	0.1	0.02	0.07	0.05	0.02	0.03	0.05	0.03	0.03
EV/Sales	- -	2.56	4.17	3.89	5.34	4.79	5.44	6.81	6.53	8.87	10.54	9.16	7.9	5.69	6.2
EV/EBITDA	- -	9.2	14.58	12.47	18.59	16.86	19.76	23.43	21.62	26.49	30.53	27.41	24.73	16.66	16.6
EV/EBIT	- -	11.88	17.8	14.69	21.91	20.22	24.61	28.45	26.74	32.43	36.94	32.71	28.97	19.26	18.92
EV/Cash Flow to Firm	- -	9.04	15.48	15.26	23.12	15.83	25.71	30.52	34.91	31.37	44.96	88.77	45.6	18.54	18.22
EV/Free Cash Flow to Firm	- -	7.81	13.16	12.66	19.5	14.11	22.1	26.85	30.13	27.84	38.9	62.4	38.55	17.17	17.23
Diluted Market Cap	- -	4,151	7,057	6,785	9,531	8,458	11,069	15,983	16,038	25,635	33,464	32,349	32,175	26,116	32,415
Diluted Enterprise Value	-635	3,592	6,482	6,180	9,115	8,899	11,325	16,075	17,161	26,471	33,962	32,993	33,527	26,752	32,057
EV per Share	- -	2.4	4.42	4.27	6.38	6.28	7.95	11.16	11.89	18.18	23.19	22.44	22.74	18.13	21.76
TTM Sales	1,243	1,369	1,514	1,555	1,679	1,839	2,067	2,340	2,607	2,957	3,197	3,578	4,223	4,685	5,146
TTM EBITDA	338	380	433	485	482	523	569	680	787	990	1,104	1,196	1,350	1,600	1,923
TTM Operating Income	267	294	355	411	409	436	457	560	636	809	912	1,002	1,152	1,384	1,687
TTM Cash Flow to Firm	285	387	408	396	388	557	437	522	487	836	750	369	732	1,438	1,752
TTM Free Cash Flow to Firm	358	448	480	477	460	625	509	594	565	942	866	525	866	1,553	1,852

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	9.34	14.87	14.36	20.94	13.74	22.8	27.72	29.9	28.23	39.21	63.78	38.89	17.23	17.5
EV/EBIT	- -	11.88	17.8	14.69	21.91	20.22	24.61	28.45	26.74	32.43	36.94	32.71	28.97	19.26	18.92
Enterprise Value	-635	3,497	6,315	6,044	8,967	8,814	11,240	15,940	17,009	26,240	33,702	32,778	33,376	26,658	31,920
Low Price	- -	2.73	3.55	4.37	4.7	5.13	5.78	7.35	9.69	11.1	17.41	22	1.9	13.72	11.91
EV/Sales	- -	2.56	4.17	3.89	5.34	4.79	5.44	6.81	6.53	8.87	10.54	9.16	7.9	5.69	6.2
EV/EBITDA	- -	9.2	14.58	12.47	18.59	16.86	19.76	23.43	21.62	26.49	30.53	27.41	24.73	16.66	16.6
Price/Earnings	- -	15.92	22.43	19.26	26.59	23.76	32.09	50.21	39.26	40.86	69.98	41.23	35.68	25.49	23.04
Price/Earnings Average	- -	16.28	174.69	19.05	21.66	22.82	27.15	39.68	36.8	33.3	59.97	45.21	35.48	25.13	22.24
Price/Earnings High	- -	17.35	205.49	19.75	26.59	26.58	32.09	51.03	39.26	42.33	69.98	55.73	39.54	31.7	31.42
Price/Earnings Low	- -	15.63	16.52	17.91	18.71	20.41	23.87	33.25	34.28	25.77	53.32	41.23	3.11	19.76	12.47
Price/Book Value	- -	2.97	4.37	3.73	4.75	3.87	4.74	6.51	6.52	8.97	10.78	8.89	7.53	5.21	5.31
Price/Book Value Average	- -	3.04	34.02	3.69	3.87	3.72	4.01	5.15	6.11	7.31	9.24	9.75	7.49	5.14	5.12
Price/Book Value High	- -	3.23	40.02	3.83	4.75	4.34	4.74	6.62	6.52	9.29	10.78	12.02	8.34	6.48	7.24
Price/Book Value Low	- -	2.91	3.22	3.47	3.34	3.33	3.53	4.31	5.69	5.65	8.21	8.89	0.66	4.04	2.87
Price/Tangible Book Value	- -	3.13	5.36	4.67	7.35	24.93	17.34	20.45	-51.88	160.24	58.75	29.8	39.67	16.94	13.14
Price/Tangible Book Value Average	- -	3.2	41.72	4.62	5.99	23.95	14.67	16.16	-48.62	130.59	50.35	32.68	39.44	16.7	12.69
Price/Tangible Book Value High	- -	3.41	49.08	4.79	7.35	27.9	17.34	20.78	-51.88	165.97	58.75	40.28	43.96	21.07	17.92
Price/Tangible Book Value Low	- -	3.07	3.95	4.34	5.17	21.43	12.9	13.54	-45.29	101.06	44.76	29.8	3.45	13.13	7.11
Price/Sales	- -	2.96	4.55	4.28	5.59	4.55	5.31	6.77	6.09	8.59	10.39	8.98	7.58	5.55	6.27
Price/Sales Average	- -	3.03	35.43	4.23	4.55	4.37	4.5	5.35	5.71	7	8.9	9.85	7.54	5.48	6.05
Price/Sales High	- -	3.23	41.67	4.39	5.59	5.09	5.31	6.88	6.09	8.9	10.39	12.14	8.4	6.91	8.55
Price/Sales Low	- -	2.91	3.35	3.98	3.93	3.91	3.95	4.48	5.32	5.42	7.91	8.98	0.66	4.31	3.4
Price/Cash Flow	- -	10.59	17.11	16.99	24.49	15.28	26.53	31.38	34.6	31.67	45.07	91.51	46.19	18.57	18.43
Price/Cash Flow Average	- -	10.83	133.19	16.81	19.95	14.68	22.44	24.8	32.43	25.81	38.63	100.35	45.93	18.31	17.79
Price/Cash Flow High	- -	11.54	156.68	17.43	24.49	17.1	26.53	31.89	34.6	32.8	45.07	123.71	51.19	23.09	25.13
Price/Cash Flow Low	- -	10.4	12.6	15.8	17.23	13.13	19.73	20.78	30.21	19.97	34.34	91.51	4.02	14.4	9.98
Price/Free Cash Flow Average	- -	9.56	115.78	14.21	17.06	13.19	19.29	21.91	28.02	23	33.6	69.95	38.67	16.98	16.89
Price/Free Cash Flow High	- -	10.18	136.2	14.73	20.94	15.37	22.8	28.17	29.9	29.24	39.21	86.22	43.1	21.42	23.86
Price/Free Cash Flow Low	- -	9.18	10.95	13.35	14.74	11.8	16.96	18.36	26.1	17.8	29.87	63.78	3.39	13.35	9.47
EV/Sales Average	- -	2.62	35.05	3.84	4.31	4.61	4.62	5.39	6.14	7.28	9.06	10.03	7.86	5.61	5.99
EV/Sales High	- -	2.82	41.29	4	5.34	5.33	5.44	6.92	6.53	9.18	10.54	12.32	8.72	7.04	8.48
EV/Sales Low	- -	2.5	2.97	3.59	3.68	4.15	4.08	4.52	5.75	5.7	8.07	9.16	0.98	4.44	3.33
EV/EBITDA Average	-1.88	9.44	122.55	12.32	14.99	16.23	16.79	18.55	20.35	21.75	26.23	30	24.6	16.43	16.02
EV/EBITDA High	-1.88	10.16	144.4	12.82	18.59	18.77	19.76	23.81	21.62	27.41	30.53	36.86	27.3	20.62	22.7
EV/EBITDA Low	-1.88	9.01	10.39	11.5	12.82	14.61	14.81	15.56	19.05	17.02	23.37	27.41	3.07	13	8.9
EV/EBIT Average	-2.38	12.2	149.59	14.52	17.66	19.46	20.91	22.52	25.17	26.62	31.74	35.81	28.81	18.99	18.25
EV/EBIT High	-2.38	13.12	176.25	15.1	21.91	22.51	24.61	28.91	26.74	33.56	36.94	43.99	31.98	23.84	25.87
EV/EBIT Low	-2.38	11.63	12.68	13.56	15.11	17.52	18.45	18.89	23.57	20.84	28.28	32.71	3.59	15.03	10.14
Last Price	- -	2.78	4.82	4.7	6.68	5.97	7.77	11.1	11.1	17.6	22.85	22	21.82	17.7	22
High Price	- -	3.03	44.15	4.82	6.68	6.68	7.77	11.28	11.1	18.23	22.85	29.74	24.18	22.01	30
Enterprise Value Average	-635	3,591	53,078	5,974	7,228	8,482	9,549	12,616	16,011	21,539	28,955	35,883	33,194	26,288	30,801
Enterprise Value High	-635	3,862	62,539	6,214	8,967	9,810	11,240	16,197	17,009	27,149	33,702	44,084	36,840	32,995	43,657
Enterprise Value Low	-635	3,424	4,500	5,577	6,185	7,636	8,427	10,586	14,991	16,858	25,797	32,778	4,141	20,807	17,116

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	152	142	142	140	140	141	142	143	144	145	146	146	147	147	146
Diluted Weighted Avg Shares	1,572	1,493	1,464	1,444	1,427	1,417	1,425	1,440	1,445	1,457	1,465	1,470	1,475	1,476	1,473
Basic Weighted Avg Shares	1,525	1,459	1,430	1,415	1,405	1,402	1,414	1,428	1,431	1,443	1,453	1,461	1,468	1,470	1,467
Revenue per Share	0.82	0.94	1.06	1.1	1.2	1.31	1.46	1.64	1.82	2.05	2.2	2.45	2.88	3.19	3.51
EBITDA per Share	0.22	0.26	0.3	0.34	0.34	0.37	0.4	0.48	0.55	0.69	0.76	0.82	0.92	1.09	1.31
Operating Income per Share	0.18	0.2	0.25	0.29	0.29	0.31	0.32	0.39	0.44	0.56	0.63	0.69	0.78	0.94	1.15
Basic EPS, GAAP	0.15	0.17	0.21	0.24	0.25	0.25	0.24	0.22	0.28	0.43	0.33	0.53	0.61	0.69	0.95
Basic EPS from Cont Ops	0.15	0.17	0.21	0.24	0.25	0.25	0.24	0.22	0.28	0.43	0.33	0.53	0.61	0.69	0.95
Diluted EPS, GAAP	0.14	0.17	0.21	0.24	0.25	0.25	0.24	0.22	0.28	0.43	0.32	0.53	0.61	0.69	0.95
Diluted EPS from Cont Ops	0.14	0.17	0.21	0.24	0.25	0.25	0.24	0.22	0.28	0.43	0.32	0.53	0.61	0.69	0.95
Dividend per Share	- -	- -	0.07	0.1	0.11	0.12	0.13	0.14	0.15	0.16	0.16	0.17	0.18	0.19	0.21
Cash Flow per Share	0.19	0.26	0.28	0.28	0.27	0.39	0.29	0.35	0.32	0.56	0.51	0.24	0.47	0.95	1.19
Free Cash Flow per Basic Share	0.14	0.22	0.23	0.22	0.22	0.34	0.24	0.3	0.27	0.48	0.43	0.13	0.38	0.87	1.13
Cash & Equivalents per Share	0.48	0.55	0.61	0.64	0.51	0.52	0.58	0.13	0.1	0.32	0.2	0.19	0.16	0.16	0.82
Book Value per Share	0.73	0.94	1.1	1.26	1.41	1.54	1.64	1.7	1.7	1.96	2.12	2.47	2.9	3.4	4.15
Tangible Book Value per Share	0.95	0.89	0.9	1.01	0.91	0.24	0.45	0.54	-0.21	0.11	0.39	0.74	0.55	1.04	1.67

ResMed Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)